Anthem, Inc. (ANTM) Stock Rating Reaffirmed by Cantor Fitzgerald

Anthem, Inc. (NYSE:ANTM)‘s stock had its “buy” rating reiterated by equities researchers at Cantor Fitzgerald in a report released on Thursday, May 11th. They currently have a $136.00 target price on the stock. Cantor Fitzgerald’s price target points to a potential downside of 28.41% from the company’s previous close.

The analysts wrote, “On Thursday, May 11, 2017, the Delaware Chancery Court ruled against Anthem and allows Cigna to terminate the merger agreement with Anthem. The ruling has no impact on our investment thesis, as we assigned a very low probability to Anthem’s ability to complete the merger.””

ANTM has been the topic of several other reports. Jefferies Group LLC lifted their target price on Anthem from $151.00 to $172.00 and gave the company a “hold” rating in a research report on Thursday, February 2nd. Citigroup Inc. boosted their price objective on Anthem from $151.00 to $172.00 and gave the company a “buy” rating in a research report on Monday, January 23rd. Royal Bank of Canada boosted their price objective on Anthem from $169.00 to $174.00 and gave the company an “outperform” rating in a research report on Thursday, February 2nd. Sanford C. Bernstein lifted their target price on Anthem from $202.00 to $212.00 and gave the stock an “outperform” rating in a report on Friday, April 28th. Finally, Barclays PLC lifted their target price on Anthem from $159.00 to $169.00 and gave the stock an “equal weight” rating in a report on Thursday, February 2nd. Eleven analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $164.56.

Analyst Recommendations for Anthem (NYSE:ANTM)

Shares of Anthem (NYSE ANTM) opened at 189.96 on Thursday. The company has a market capitalization of $50.34 billion, a PE ratio of 18.41 and a beta of 0.68. The company’s 50-day moving average price is $182.60 and its 200-day moving average price is $163.91. Anthem has a 1-year low of $114.85 and a 1-year high of $190.26.

Anthem (NYSE:ANTM) last posted its earnings results on Wednesday, April 26th. The company reported $4.68 EPS for the quarter, topping the Zacks’ consensus estimate of $3.85 by $0.83. The business had revenue of $22.32 billion during the quarter, compared to analyst estimates of $21.23 billion. Anthem had a return on equity of 13.13% and a net margin of 3.19%. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter last year, the company earned $3.46 EPS. On average, equities analysts expect that Anthem will post $11.78 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 23rd. Investors of record on Friday, June 9th will be given a $0.65 dividend. This represents a $2.60 annualized dividend and a dividend yield of 1.37%. The ex-dividend date is Wednesday, June 7th. Anthem’s payout ratio is 25.22%.

WARNING: This article was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.com-unik.info/2017/06/17/anthem-inc-antm-rating-reiterated-by-cantor-fitzgerald-updated-updated-updated.html.

In other news, EVP Gloria M. Mccarthy sold 15,187 shares of the stock in a transaction dated Monday, April 3rd. The shares were sold at an average price of $166.38, for a total transaction of $2,526,813.06. Following the sale, the executive vice president now directly owns 59,144 shares of the company’s stock, valued at approximately $9,840,378.72. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Ramiro G. Peru sold 2,681 shares of the stock in a transaction dated Tuesday, May 30th. The stock was sold at an average price of $181.58, for a total transaction of $486,815.98. Following the sale, the director now directly owns 13,571 shares in the company, valued at $2,464,222.18. The disclosure for this sale can be found here. Insiders have sold a total of 19,290 shares of company stock worth $3,276,368 over the last ninety days. 0.36% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ANTM. FTB Advisors Inc. increased its stake in shares of Anthem by 11.1% in the first quarter. FTB Advisors Inc. now owns 668 shares of the company’s stock worth $117,000 after buying an additional 67 shares in the last quarter. Westside Investment Management Inc. increased its stake in Anthem by 33.6% in the first quarter. Westside Investment Management Inc. now owns 795 shares of the company’s stock valued at $131,000 after buying an additional 200 shares during the period. Focused Wealth Management Inc bought a new stake in Anthem during the first quarter valued at $149,000. Guardian Life Insurance Co. of America increased its stake in Anthem by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,016 shares of the company’s stock valued at $168,000 after buying an additional 7 shares during the period. Finally, Point72 Asia Hong Kong Ltd bought a new stake in Anthem during the first quarter valued at $181,000. 88.74% of the stock is currently owned by institutional investors and hedge funds.

About Anthem

Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.

What are top analysts saying about Anthem Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Anthem Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit